These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10744167)

  • 41. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anesthetic management of a patient with blood coagulation factor XII deficiency].
    Okuda T; Takita A; Ikemoto T; Fukuda I; Karasawa F; Satoh T
    Masui; 2001 May; 50(5):535-7. PubMed ID: 11424474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi a highly purified, doubly inactivated FVIII/VWF concentrate.
    Hernandez-Navarro F; Quintana M; Jimenez-Yuste V; Alvarez MT; Fernandez-Morata R
    Haemophilia; 2008 Sep; 14(5):963-7. PubMed ID: 18624696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor.
    Grossmann RE; Geisen U; Schwender S; Keller F
    Thromb Haemost; 2000 Apr; 83(4):633-4. PubMed ID: 10780333
    [No Abstract]   [Full Text] [Related]  

  • 47. A case of coagulation factor XII deficiency showed weak clot-formation.
    Tatsumi Y; Araki J; Fukuda T; Kojima K; Tatsumi N
    Osaka City Med J; 1983; 29(1):99-104. PubMed ID: 6676701
    [No Abstract]   [Full Text] [Related]  

  • 48. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modification of von Willebrand disease after liver transplantation.
    Schulman S; Ericzon BG; Eleborg L
    Thromb Haemost; 2001 Dec; 86(6):1588-9. PubMed ID: 11776336
    [No Abstract]   [Full Text] [Related]  

  • 50. A novel mutation in a patient with congenital coagulation factor XII deficiency.
    Feng Y; Ye X; Pang Y; Dai J; Wang XF; Zhou XH
    Chin Med J (Engl); 2008 Jul; 121(13):1241-4. PubMed ID: 18710647
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hemopericardium in hypodermosis in a child with partial factor IX and factor XII deficiencies].
    Larbre F; Excler JL; Guilhot J; Tran Manh Sung R; Eyraud M
    Pediatrie; 1981 Jun; 36(4):297-301. PubMed ID: 7290850
    [No Abstract]   [Full Text] [Related]  

  • 52. Congenital coagulation disorders in northern Alberta and surrounding areas of Canada.
    Mant MJ
    Clin Invest Med; 1980; 3(3-4):213-9. PubMed ID: 6971723
    [No Abstract]   [Full Text] [Related]  

  • 53. [The combined deficiency of factor VIII and factor XII in a family. (preliminary report) (author's transl)].
    Hosokawa Y; Yachi A; Wada T; Kurokawa I
    Rinsho Ketsueki; 1974 Aug; 15(8):923-7. PubMed ID: 4475154
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan.
    Chen YC; Chao TY; Cheng SN; Hu SH; Liu JY
    Haemophilia; 2008 Jul; 14(4):768-74. PubMed ID: 18498402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
    Girolami A; Ruzzon E; Tezza F; Scandellari R; Scapin M; Scarparo P
    Haemophilia; 2008 Mar; 14(2):323-8. PubMed ID: 18081833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Review of patients studied for coagulopathy in a Hematology/Oncology unit].
    Romero I; Conde N; García Aldana D; Ruano A; Fernández-Teijeiro A
    An Pediatr (Barc); 2016 Feb; 84(2):85-91. PubMed ID: 26006274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute myocardial infarction in a patient with von Willebrand disease: pathogenetic dilemmas and therapeutic challenges.
    Arjomand H; Aquilina P; McCormick D
    J Invasive Cardiol; 2002 Oct; 14(10):615-8. PubMed ID: 12368516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased factor XII activity is associated with recurrent IVF-ET failure.
    Matsubayashi H; Sugi T; Suzuki T; Uchida N; Atsumi H; Izumi S; Mikami M
    Am J Reprod Immunol; 2008 Apr; 59(4):316-22. PubMed ID: 18294355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiopulmonary bypass and Factor XII deficiency.
    Candio J; Prager D
    Pa Med; 1981 Feb; 84(2):40. PubMed ID: 7232002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.